Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Gene expression profiling wikipedia , lookup
Oncogenomics wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Microevolution wikipedia , lookup
Genome (book) wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Epigenetics in learning and memory wikipedia , lookup
History of genetic engineering wikipedia , lookup
Human–animal hybrid wikipedia , lookup
SUSCEPTIBILITY T O TRANSMITTED LEUKEMIA OCCURRING I N PURE BRED AND HYBRID MICE' M. D. SCHWEITZER AKD J. FURTH (From the Department of Pathology, Cornell University Medical College, New York) Many investigators have called attention to the importance of heredity in breast cancer, lung tumors, leukemia, and other neoplasms of mice (cf. 1). Recently, the staff of the Roscoe B. Jackson Laboratory ( 2 ) has demonstrated the r61e of non-genetic factors and emphasized the need for a reinvestigation of the part played by heredity in the development of tumors.2 Experiments have been undertaken in this laboratory to determine the factors responsible for spontaneous leukemia and for susceptibility to transmissible leukemia. The studies on susceptibility to transmissible leukemia are described in this paper. The older literature concerning leukemia of mammals has been reviewed by Opie ( 3 ) . It is only within the past decade that the disease has been successfully transmitted in mice. Transmissible strains have been described by Korteweg (4), Richter and MacDowell ( 5 ) , Mercier and Gosselin ( 6 ) , Krebs, Rask-Nielsen and Wagner ( 7 ) , Dobrovolskai'a-Zavadskai'a (8), Lawrence and Gardner ( 9 ) , Lewis (lo), and workers in this laboratory (11). There are few reports on the heredity of transmissible leukemia. The most extensive of these is that by MacDowell and Richter ( 1 2 ) . Other workers have given only fragmentary data, MacDowell and Richter inoculated cells of their Line 1, originating in the highly leukemic stock C58, into other mice of the same stock, into mice of the Storrs-Little stock, which had no previous history of leukemia, and into first and second generation hybrids ( F1and Fp) and back-cross combinations. These cells failed to grow in Storrs-Little mice but produced leukemia in almost every mouse of the C58 stock and of the first hybrid generation. The frequency of the disease among other hybrid combinations, including back-crosses, suggested that a single dominant gene was responsible for susceptibility. Cells from another C58 mouse (Line A) gave somewhat different results in hybrid combinations. The percentages of susceptible mice were much smaller and variable. The ratios of susceptible to resistant mice observed in back-cross generations suggested that from two to seven genes might be operating. On the basis of genetic studies of spontaneous leukemias MacDowell and Richter ( 1 3 ) concluded that a semi-dominant gene determined the incidence of the disease. Slye ( 14), however, believes that her results are best explained by assuming a single recessive gene responsible for the occurrence of leukemia and an additional localization factor. 1This investigation was aided by grants from The Jane Coffin Childs Memorial Fund for Medical Research, The International Cancer Research Foundation, and The Anna Fuller Fund. *Earlier observations of Lathrop and Loeb (J. Exper. Med. 28: 475, 1918) suggested the existence of maternal influence on susceptibility to breast tumors. 2 24 SUSCEPTIBILITY TO TRANSMITTED LEUKEMIA I N MICE 225 Following the pioneer investigations of Tyzzer and Little (15) and of Loeb (19b), there have been numerous studies on hereditary susceptibility of mice to transplanted tumors. Most of these have been reviewed by Gorer (16). Bittner’s studies ( 17) on transplantable adenocarcinoma of the mammary gland parallel the experiments to be reported here, He studied tumors originating in stocks A (albino) and D (dilute brown) mice and in first generation hybrids between the two stocks. The tumors originating in the pure stocks could be transplanted (a) within the strain of origin, ( b ) to the first generation hybrids, and (c) to mice resulting from matings of these hybrids with the stock of origin; but these tumors failed to grow in the opposite stock. They grew in a small percentage of second generation hybrids and in progeny of the mating of F to the opposite pure stock. The tumors arising in F, hybrids were transmissible to almost all F, animals; the inoculations were successful in only small percentages of mice of the second filial generation and of both types of back-cross mating, and failed in each parental stock. Bittner concluded that the simultaneous presence of seven or eight genes was required for transmission of tumors originating in F, hybrids. The factors influencing the success of transplantation are numerous and Loeb (19b) doubts that this method is suitable for analysis of genes. NOMENCLATURE In the description of our experiments the following terms are used as indicated: Stock: Inbred, genetically homogeneous mice. The specific traits of each stock are given in the text. Strain: Leukemic cells or fragments of tumor originating in a single stock and maintained by inoculation in related mice, or preserved in the frozen state. Line: Cells or fragments from a single host, maintained as stated above. F,: Progeny of mating Ak and Rf, or reciprocally. F,: Progeny of mating F, with F,. F,: Progeny of mating F, with F,. Back-cross: Progeny of mating F, with either parental stock. MATERIAL AND METHODS Two stocks of mice, designated as Ak and Rf respectively, and hybrids between them were studied. Both stocks have been inbred in this laboratory since 1928. Their origin has been described elsewhere (1 la). Stock Ak is noteworthy for a high incidence of spontaneous leukemia among members surviving seven months or longer, the frequency being approximately 70 per cent in the past eight generations. Additional evidence that the strain is genetically homogeneous is afforded by the observation that the incidence of leukemia is the same within a litter whether or not the parents had the disease. Lymphatic leukemia is the type commonly occurring in stock Ak. In the Rf stock leukemia is rare; if it occurs, it is usually myeloid or monocytic. The frequency in this strain has been approximately 1 or 2 per cent. Inoculations were made with leukemic cell suspensions obtained from the spleen, lymph nodes, or leukemic tumors, according to procedures previously described ( l l c ) . Young adult mice, approximately five to eight weeks old, were used in the transmission experiments. 226 M. D. SCHWEITZER AND J. FURTH All but two of the transmissible strains studied were of the lymphoid type. One strain of Ak leukemia (Akh 106) was myeloid and the Rf strain (No. 385) was monocytic (18). TRANSMISSION EXPERIMENTS Table I, a survey of the transmission experiments, shows the results of inoculation of leukemias occurring in pure stocks and in hybrids into pure bred mice and into hybrids of known genetic constitution. The table shows that leukemia occurring in hybrids behaves like that arising in Ak mice. TABLE I: Transmissibility of Mouse Leukemia * Leukemia occurring in Stock A t I 1 Stock Rf I 1 FI Hybrid Fa Hybrid Fa Hybrid R X Ak Fi X Rf I _ _ - Stock A k . . . . . . . . . . . . Stock R f . . . . . . . . . . . . F1 Hybrids.. . . . . . . . . FI Hybrids.. . . . . . . . F1 Back-cross with Ak . Excellent Failed Excellent Excellent - Failed Excellent Failed Failed - Excellent Excellent Excellent Excellent Excellent Good Fair Variahle Fair Good Fair Fair Fair Fair Fair Excellent Fair Excellent Poor Poor - - * Designation of the success of inoculation: excellent = approximately 100 per cent; good = 75 per cent: fair 50 per cent: poor = 25 per cent; failed = 0 per cent. =i Transmission of Leukemia Occurring in Stock A k : Transmission of leukemia occurring in mice of stock Ak is regularly successful within the same stock and just as regularly fails in Rf hosts (Table 11). The malignant lymphocytes of an Ak mouse were successfully transferred to nearly all F, hybrid mice tested and in half of the progeny of F, mice mated to Rf. TABLE 11: Transmission Exfieriments with A k Leukemia * Mice 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. Ak stock Rf stock Fi Fa FJ Ak X FI Rf X FI Ak X Fa Rf X Fz Ak X (Fi/Rf) Rf X (FiIRf) Rf X (FJAk) Number of mice injected 145 29 20 43 77 33 53 11 58 7 12 24 Successful inoculations Expectation Number of experiments performed 25 4 2 5 10 7 8 2 10 1 1 2 * The transmissible strain used in these experiments (Akf 5 , lymphatic leukemia) is usually fatal in about ten days. The expected values are computed on the hypothesis that a single dominant gene is responsible for susceptibility to transmitted leukemia. Accordingly, all mice receiving a leukemic gene from one or both parents should be susceptible, all others resistant. Mice in rows 1, 3, 6, 8 and 10 are expected to be susceptible, those in row 2 resistant. In rows 4, 5 and 12, mendelian 227 SUSCEPTIBILITY TO TRANSMITTED LEUKEMIA IN MICE segregation should yield three susceptible among every four mice; half of the mice in rows 7 and 9 should be susceptible and one of four in row 11. Most of the results shown in Table I1 are consistent with the interpretation that a single dominant gene determines the fate of injected leukemic cells. For Fzand F, mice this interpretation should yield a frequency of 75 per cent susceptibility. Results with F, mice are close to this predicted value (72 per cent of 43 injected mice). For F3 mice, however, the figures are definitely lower (50 per cent of 77 injected mice). The back-crosses of F, and F, to the Rf stock also yielded susceptibility values below the 50 per cent expectation (38 per cent of 53 injected mice and 36 per cent of 58 injected mice, respectively). The significance of these findings is discussed below. Transmission of Leukemia Occurring in Stock Rf: Data for attempted transfers of Rf leukemia comparable to the preceding series are presented in Table 111. The strain used (Rfb 385) is monocytic leukemia, which is usually fatal in about three weeks. The results obtained are compatible for the most part with the single gene hypothesis. TABLE I I I : Transmission ExPeriments with Rf Leukemia Mice Ak stock Rf stock Fi Fa Fa Rf X Fi Rf X Fa Ak X Fs Rf X (Fi/Rf) Number of mice injected 23 33 18 41 52 13 16 4 5 Successful inoculations Expectation 0 27 or 28 (83%) 18 (100%) 21 ( 51%) 32 ( 62%) 13 (100%) 14 ( 88%) 3 ( 75%) 5 (100%) 0 33 (100%) 18 (100%) 31 75%) 39 ( 75%) 13 (100%) 16 (100%) 2 ( 50%) 5 (100%) Number of experiments performed 4 9 4 5 7 2 2 1 1 Transmission of Leukemia Occurring in F , Hybrids: Table IV shows the results of transmission experiments obtained with F, leukemias. Transfer failed in all of 29 Rf animals tested, but was successful in 55 of 56 Ak mice and in 17 of 18 F, mice that were injected. TABLE IV: Transmission Experiments w’th FIHybrid Leukemia Mice Number of mice injected Successful inoculations Expectation Number of experiments performed Four strains of lymphoid leukemia were used in these experiments. Since the results were essentially the same, they are presented in one table. Three strains (Ha 14, Ha 16, Ha 17) originated in mice resulting from the mating Ak X Rf; the fourth (Hb 4 ) came from the reciprocal mating. 228 M. D. SCHWEITZER AND J. FURTH Transmission of F z Leukemias: The results of inoculation with leukemia originating in the F, hybrids (Strain Hb Sol), shown in Table V, are similar to those of leukemia originating in F, and Ak mice. TABLE V: Transmission Experiments w'th Fe Hybrid Leukemia Mice Number of mice injected Ak stock Rf stock Fi FZ 19 20 6 60 65 8 29 Fa Ak X FI Rf X FI Ak X Fz Rf X Fa Ak X (FdRf) 5 6 13 Successful inoculations 17 ( 89%) 0 6 (100%) 28 ( 47%) 30 ( 46%) 4 ( 50%) 10 ( 35%) 1 ( 20%) 2 ( 40%) 10 ( 77%) Expectation Number of experiments performed 19 (100%) 0 6 (100%) 45 ( 75%) 46 ( 75%) 8 (100%) 15 ( 50%) 5 (100%) 3 ( 50%) 13 (100%) 4 4 1 6 10 1 6 1 1 2 F, X A k Leukemia: A few series of inoculations of leukemia arising in the mating of F, with Ak (Strain Ha 230) are given in Table VI. The results are similar to those of the Ak, F, and F, leukemias. TABLE VI: Transmission Experiments m'th R X Ak Leukemia Mice Number of mice injected Successful inoculations Expectat ion Number of experiments performed Comment: These experiments indicate that all leukemias occurring among hybrids resemble genetically the leukemias occurring in the pure leukemic stock. They will be spoken of collectively as Ak-type leukemias. If the results with the hybrid leukemias are considered alone, the number of successful inoculations falls short of numerical agreement with the predicted values for a single dominant gene. Conspicuously higher values were obtained only in an occasional small test, and can be explained by chance occurrence. These findings are in agreement with the hypothesis of dominance, since all hybrid combinations have a substantial proportion of susceptible individuals. The deficiency observed may be interpreted as due to the presence of two dominant genes governing susceptibility, or to some other unknown factors interfering with the results of inoculations. Further experiments are needed to clarify these observations. VARIABILITY According to the hypothesis that susceptibility to transmissible leukemia is determined by a single dominant gene, all individuals fall into three genotypes, with both Ak and Rf types of leukemia. With reference to Ak-type leukemia, the genotypes are AA, Aa, aa, the first two being susceptible, the last resistant. The different matings will result in different susceptibility frequencies among SUSCEPTIBILITY TO TRANSMITTED LEUKEMIA IN MICE 229 the progeny. The genetic hypothesis can also be tested by determining the variability of the success of inoculations. For example, with both Ak and Rf leukemias it is to be expected that %e of the F, X F, matings will yield progeny all of which are susceptible, that I/le will yield resistant offspring, ?hoffspring with 75 per cent and % with 50 per cent susceptibility. Twenty-two combinations were tested in a total of 196 experiments, each with an average of 6.1 animals. No variation is postulated in 150 experiments, and only twelve of these gave conspicuously divergent results. More widespread differences were encountered in forty-four experiments in which variability was expected. For example, the average susceptibility of F, mice is expected to be 75 per cent and the range 0-50-75 and 100 per cent. The sixteen experiments performed yielded the following results : Mice No.injected 8 Percent 3. 88 No. + Total number. Individual experiments 7 13 4 30 4 3 75 13 5 38 7 0 0 5 4 80 8 6 75 Observed Predlcted 129 72 56 129 7 8 8 6 9 9 9 8 6 5 4 2 6 4 4 5 100 86 63 50 33 66 44 44 63 7 7 91 75 Inasmuch as the variability predictions are based on the genotypes of the particular parents, additional experiments were performed with litter mates. The results of the thirty-one experiments made, while not inconsistent with the genetical hypothesis, were not conclusive. TABLE VII 1 Duration of Life of Individual Mice of Different Genotypes after Inocdation with Cells of Strain Akf 5 Mice injected Ak stock Fz Fa FI X Rf Fa X Rf FI X Ak FI/Rf X Rf June 15, 1938 Sept. 3, 1938 days 9, 10,10 8,9,9,9,9,10 8,8,10,10,10,11, 19 9,9,9,9,10,10,16,23 9,9,9,9,10,10 days 11,12,12,12 - - 9,9,9,9,9,9,9,10,10,11, 11, 13,16 9,9,9,11 - 12, 16 9,9,9,9,9,23 DURATION OF ILLNESS IN RELATION TO HEREDITY Many investigations have shown that when mice are inoculated under standardized conditions the duration of illness is characteristic for each transmissible neoplasm, although it often decreases in the course of successive passages. Earlier investigators, however, gave little attention to the genetic constitution of the host, and the question arose whether the genotype of the latter would influence the duration of illness. The present study has shown that the genotype of the host does not influence the course of disease. This may be illustrated from data with strain Akf 5. From its origin in February 1937 until June 6, 1938, the average duration of illness was 13.7 days (twenty observations). Beginning with the series started on June 15, 1938, and continuing to date, the length of life after 230 M. D. SCHWEITZER AND J. FURTH inoculation was abruptly shortened to approximately 10 days. The length of life after inoculation has since been as follows: Numberof days Number of mice 8 11 9 40 10 20 11 7 12 5 13 2 15 1 16 3 19 1 23 2 33 1 Ninety per cent of the animals (83 of 93) succumbed between the eighth and twelfth days following inoculation. In an experiment performed on June 6, 1938, three Ak animals died after 14, 14 and 15 days, and three F1animals after 14, 14, and 16 days. The results of two experiments performed June 15 and September 3 respectively are summarized in Table VII. These data indicate that the genotype of the host exerts no influence on the duration of leukemia. DISCUSSION The Genetic Basis of Susceptibility to Leukemia: The data on transmission of leukemia originating in pure stocks of mice are consistent with the interpretation that dominant genes, single or possibly double, are responsible for susceptibility to the disease (Tables I1 and 111). These results confirm the findings of MacDowell and Richter with their Line I. Loeb (19) and other investigators (cited by Gorer, 16) have suggested that many genes of both parental stocks are involved in susceptibility of hybrids to transmissible neoplasms and that the genetic differences are not specific for tumors. Previously this problem of specific genetic factors for susceptibility could not be directly ascertained, inasmuch as the tumors studied originated in only one of the parental stocks. The leukemias of hybrid origin now available permit a further analysis of this problem. While the tissue genes of hybrids are derived in equal number from both parent stocks, all leukemias of hybrid origin thus far investigated conform to the pattern of Ak leukemias (Table VIII). This is indicative of the presence of specific genes governing susceptibility to leukemia. The results are incompatible with the theory that genes of mixed origin determine susceptibility (Table VIII) . TABLE VIII: Predicted Ratios for Susceptibility of Mice to Leukemias Originating i n Hybrids Corn. pared with Ratios Found Per cent of successful inoculations on basis of the fallowing possibilities concerning the genetic constitution of leukemic cells Results observed Mice injected Ak type, single dominant Rf type, single dominant Miped, dominant Mixed, recessive Per cent + -.___ Ak stock Rf stock FI F2 100 0 100 75 0 100 100 0 0 100 75 Intermediate 0 0 100 100 96 0 97 44-72 It follows from the hypothesis of Loeb that leukemias of hybrids (e.g. F,) should be more readily transmissible to Fzand other hybrid mice than to mice of either parental stock. But the leukemias arising in hybrids studied by us are more easily transmitted to Ak mice than to F, hybrids. The results are especially conspicuous with Hb 501 strain (Table V). Although this strain SUSCEPTIBILITY TO TRANSMITTED LEUKEMIA IN MICE 231 of leukemia originated in an F, mouse, it was more successfully transferred to Ak and F, mice than to F, mice. These ex ts lend strong support to the view that specific hereditary differences n the Ak and Rf strains which are responsible for susceptibility to transmitted leukemia are segregated in the hybrids. The hybrid leukemias thus far observed were of the Ak type, but it is possible that occasionally leukemias of the Rf type may arise among the hybrids. Bittner's experiments with transmissible breast tumors arising in hybrids gave quite different results from those here reported. The tumors originating in either parental stock gave results comparable to ours. The tumors arising in F, mice, however, failed to take in the parental stocks, although they were grafted with some success into F, and other hybrid mice; this agrees with the postulated values for factors of mixed origin shown in the third and fourth columns of our Table VIII. These findings support the opinion of Loeb that the genetic factors for adenocarcinomata as observed by Bittner are not necessarily tumor-specific. Grafting of normal tissues might yield similar results. In our experiments, however, specific genetic susceptibility for transmitted leukemia appears necessary for the success of inoculations. With regard to neoplasms originating in a pure stock, our transmission experiments are comparable to those of previous investigators. The study of tumors originating in hybrids contributes essential data concerning the mode of inheritance of susceptibility to transmissible neoplasms. Are Susceptibility Factors for A k and Rf Leukemia Allelomorphic? If Ak leukemic factors were dominant over Rf leukemic factors or vice versa, then every mouse susceptible to a strain from one stock should be resistant to strains of the other and every mouse in each hybrid combination should succumb to one. The fact that both leukemic factors are dominant is inconsistent with this supposition. Furthermore, if susceptibilities for these two types of leukemia were each determined by dominant and allelomorphic genes (single or multiple), the F, and back-cross percentages in the corresponding columns of Tables I1 to VI should add up to a maximum of unity (100 per cent), but this is not the case, the values being consistently above 100 per cent. Maternal Influences: Although many transfers were made in reciprocal crosses, no significant differences were observed. I n the experiments with F, hybrid leukemias four strains were tested and in one the maternal line was Rf, in three Ak. These experiments are not sufficiently extensive, however, to disclose small maternal differences. Genetic Behavior of Leukbmia of Different Histological Types: The Rfb 385 strain studied is monocytic leukemia, Akh 106 is myeloid, all other strains are lymphoid. The myeloid strain Akh 106 gave results comparable to those recorded for Akf 5 and other Ak leukemias of lymphoid type. Our data do not disclose any difference concerning the susceptibility factors for leukemias of different cell types. SUMMARY AND CONCLUSIONS Spontaneous leukemias originating in the highly leukemic stock Ak, in stock Rf in which the incidence of leukemia is low, and in first generation and other hybrids, were inoculated into mice of each of the pure stocks and of 232 M. D. SCHWEITZER AND J. FURTH various hybrid combinations. The leukemias arising in different hybrids behaved in transmission experiments like the Ak leukemias. All of these leukemias can be transmitted to almost every member of the leukemic stock Ak and to F, generation hybrids, but not to members of stock Rf. All hybrid combinations tested have a substantial proportion of susceptible individuals, indicating dominance of inheritance; but further investigation is required to determine if one or two dominant genes are responsible for susceptibility. The duration of illness and the anatomical characteristics of leukemia are not modified by the genotype of the host. The susceptibility factors of both Ak and Rf leukemias are not allelomorphic. Evidence is presented that these genetic factors are specific for susceptibility to transmissible leukemia, and differ from those that, according to Loeb, determine susceptibility for normal tissue grafts. BIBLIOGRAPHY J. Cancer 15: 2780, 1931. HALDANE, J. B. S.: Nature 132: 265, 1933. BITTNER,J. J.: Quart. Rev. Biol. 13: 51, 1938. 1. (a) LITTLE,C. C. : Am. (b) (c) 2. (a) (b) STAFFOF JACKSON MEMORIAL LABORATORY: Science 78: 465, 1933. MURRAY, W. S., AND LITTLE,C. C.: Genetics 20: 466, 1935; Am. J. Cancer 27: 516, 1936. 3. OPIE, E. L.: Medicine 7: 31, 1928. 4. KORTEWEG, R.: Ztschr. f. Krebsforsch. 29: 455, 1929. 5 . RICHTER,M. N., AND MACDOWELL, E. C.: Proc. SOC.Exper. Biol. & Med. 26: 362, 1929; J. Exper. Med. 51: 659, 1930 and 52: 823, 1930; Physiol. Rev. 15: 509, 1935. L.: Compt. rend. Acad. d. sc. 191: 1083, 1930. 6. (a) MERCIER, (b) MERCIER, L., AND GOSSELIN, L.: Compt. rend. SOC.de biol. 106: 1216, 1931. H. C., AND WAGNER, A.: Acta radiol. Suppl. X, 1930, pp. 7. KREBS,C., RASK-NIELSEN, 1-53. 8. DOBROVOLSKAPA-ZAVADSKA~A, N.: Compt. rend. SOC.de biol. 109: 263, 1932. J, H., AND GARDNER, W. U.: Am. J. Cancer 33: 112, 1938. 9. LAWRENCE, 10. LEWIS,M. R.: Am. J. Cancer 34: 399, 1938. 11. (a) FURTH, J., SEIBOLD, H. R., AND RATHBONE, R. R.: Am. J. Cancer 19: 521, 1933. (b) FURTH,J.: J. Exper. Med. 61: 423, 1935. (c) HALL,J. W., AND KNOCKE, F. J.: Am. J. Path. 14: 217, 1938. E. C., AND RICHTER,M. N.: J. Cancer Research 14: 434, 1930; Biol. 12. MACDOWELL, Zentralbl. 52: 266, 1933. 13. (a) MACDOWELL, E. C., AND RICHTER,M. N.: Arch. Path. 20: 709, 1935. (b) MACDOWELL, E. C.: J. Heredity 28: 131, 1937, 14. SLYE,M.: in Some Fundamental Aspects of the Cancer Problem, American Association for the Advancement of Science, New York, 1937, p. 3. 15. (a) TYZZER, E. E.: J. Med. Research 32: 331, 1915. (b) LITTLE,C. C., AND TYZZER, E. E.: J. Med. Research 33: 393, 1916. 16. GORER, P. A.: J. Path. & Bact. 47: 231, 1938. 17. (a) BITTNER,J. J.: Am. J. Cancer 17: 699, 709, 717, 724, 1933; J. Genetics 29: 17, 1934. (b) BITTNER,J, J.: Am, J. Cancer 15: 2202, 1931; J. Genetics 31: 471, 1935. J,: J. Exper. Med. 69: 13, 1939. 18. FURTH, 19. (a) LOEB,L.: Ztschr. E. Krebsforsch. 7: 80, 1909; Physiol. Rev. 10: 547, 1930; Acta Unio Internat. contre Cancrum 2: 148, 1937. (b) LOEB,L,, AND WRIGHT,S.: Am, J. Path. 3: 251, 1927.